Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

Blood Cancer J. 2024 Nov 7;14(1):197. doi: 10.1038/s41408-024-01183-8.
No abstract available

Publication types

  • Letter